Evaluating the Clinical Outcomes of Drug-Coated Balloon and Conventional Balloon Angioplasty in the Management of Stent Edge Restenosis


  • Dr. Nasir Khan Registrar, Peshawar Institute of Cardiology
  • Dr. Usman Iqbal Consultant Cardiologist and Medical Specialist, CMH Sialkot
  • Dr. Muhammad Wajahat Jan Registrar Adult Cardiology, Peshawar Institute of Cardiology
  • Dr. Rahman Ullah Fellow Interventional Cardiology, Peshawar Institute of Cardiology


Anxiety, Depression, Drug-Coated Balloon Vascular Access, Perceived Stress



Coronary stenting is frequently complicated by stent edge restenosis (SER), which causes the artery to re-narrow. Drug-eluting stents (DES), plain balloon angioplasty (POBA), conventional balloon angioplasty (CBA), and drug-coated balloons (DCBs) are possible treatments for SER.


This study compared the effectiveness of DCB angioplasty with CBA to treat SER. Eighty patients were randomly assigned to receive either DCB or CBA. At 8th week and 6 months, the primary patency of the target lesion and access circuits were assessed as clinical outcomes. Furthermore, levels of perceived stress were measured by perceived stress scores.


At 8th week, the perceived stress levels of the DCB group were statistically significantly (<0.05) lower than those of the CBA group. Compared to the CBA group, the DCB group experienced improved outcomes at 6 months in all clinical outcomes.


DCB angioplasty may be superior to CBA in treating SER. In addition to enhancing vascular access, DCB angioplasty may also enhance mental and general well-being.


Anxiety, Depression, Drug-Coated Balloon Vascular Access, Perceived Stress.


DOI: https://doi.org/10.59564/amrj/01.02/013


Bergman S. Optimizing Percutaneous Coronary DCB. Lund University, Faculty of Medicine; 2022.

Garcia-Villen F, López-Zárraga F, Viseras C, Ruiz-Alonso S, Al-Hakim F, Diez-Aldama I, Saenz-del-Burgo L, Scaini D, Pedraz JL. Three-dimensional printing as a cutting-edge, versatile and personalizable vascular stent manufacturing procedure: Toward tailor-made medical devices. International Journal of Bioprinting. 2023;9(2).

Scafa Udriște A, Niculescu AG, Grumezescu AM, Bădilă E. Cardiovascular stents: A review of past, current, and emerging devices. Materials. 2021 May 12;14(10):2498.

Wacinski P, Madejczyk A, Kondracki B, O’Kane P, Wacinski J, Kijewski B, Kawiak A, Binko P, Głowniak A, Wysokiński A. Complex, high-risk, and indicated percutaneous coronary angioplasty in essentially calcified stented coronary lesions using excimer laser coronary atherectomy with contrast mix injection. Advances in DCBal Cardiology/Postępy w Kardiologii Interwencyjnej. 2023;19(3):209-16.

Wu H, Yu T, Fan T, Liao W. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis. Computational and Mathematical Methods in Medicine. 2022;2022.

Paramasivam G, Devasia T, Jayaram A, Razak A, Rao MS, Vijayvergiya R, Nayak K. In-stent restenosis of DES in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes. Anatolian journal of cardiology. 2020 Jan;23(1):28.

Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circulation: Cardiovascular Interventions. 2011 Apr;4(2):195-205.

Montelione N, Catanese V, Nenna A, Jawabra M, Verghi E, Loreni F, Nappi F, Lusini M, Mastroianni C, Jiritano F, Serraino GF. The Diagnostic Value of Circulating Biomarkers and Role of DCB for In-Stent Restenosis in Patients with Peripheral Arterial Disease. Diagnostics. 2022 Sep 12;12(9):2207.

Klein LW, Nathan S, Maehara A, Messenger J, Mintz GS, Ali ZA, Rymer J, Sandoval Y, Al-Azizi K, Mehran R, Rao SV. SCAI expert consensus statement on management of in-stent restenosis and stent thrombosis. Journal of the Society for Cardiovascular Angiography & Interventions. 2023 May 18:100971.

Cao Z, Li J, Fang Z, Feierkaiti Y, Zheng X, Jiang X. The factors influencing the efficiency of DCB. Frontiers in Cardiovascular Medicine. 2022 Oct 12;9:947776.

Cohen S, Kamarck T, Mermelstein R. Perceived stress scale. Measuring stress: A guide for health and social scientists. 1994 Jul 15;10(2):1-2.

Gobić D, Tomulić V, Lulić D, Židan D, Brusich S, Jakljević T, Zaputović L. Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study. The American Journal of the Medical Sciences. 2017 Dec 1;354(6):553-60. https://www.sciencedirect.com/science/article/pii/S0002962917304044.

Hsieh MY, Lin PS, Liao MT, Lin L, Chen TY, Boon JC, Yang TF, Wu CC. A randomised trial comparing drug-coated balloons and conventional balloons for the treatment of stent-graft stenosis in dialysis vascular access. European Journal of Vascular and Endovascular Surgery. 2023 May 18.

Liistro F, Angioli P, Ventoruzzo G, Ducci K, Reccia MR, Ricci L, Falsini G, Scatena A, Pieroni M, Bolognese L. Randomized controlled trial of acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty. Cardiovascular Interventions. 2020 Oct 12;13(19):2277-86.

Burns JW, Jensen MP, Thorn B, Lillis TA, Carmody J, Newman AK, Keefe F. Cognitive therapy, mindfulness-based stress reduction, and behavior therapy for the treatment of chronic pain: randomized controlled trial. Pain. 2022 Feb 1;163(2):376-89.

Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, Chapleau MA, Paquin K, Hofmann SG. Mindfulness-based therapy: a comprehensive meta-analysis. Clinical psychology review. 2013 Aug 1;33(6):763-71.

Gotink RA, Chu P, Busschbach JJ, Benson H, Fricchione GL, Hunink MM. Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs. PloS one. 2015 Apr 16;10(4):e0124344.

Kolstad KD, Li S, Steen V, Chung L, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech T, Furie R. Long-term outcomes in systemic sclerosis-associated pulmonary arterial hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS). Chest. 2018 Oct 1;154(4):862-71.

Kitrou PM, Katsanos K, Spyridonidis I, Theofanis M, Papachristou E, Papadoulas S, Karnabatidis D. Use of DCB in dysfunctional arteriovenous dialysis access treatment: the effect of consecutive treatments on lesion patency. Journal of Vascular and Interventional Radiology. 2019 Feb 1;30(2):212-6.

Kitrou PM, Katsanos K, Papadimatos P, Spiliopoulos S, Karnabatidis D. A survival guide for endovascular declotting in dialysis access: procedures, devices, and a statistical analysis of 3,000 cases. Expert Review of Medical Devices. 2018 Apr 3;15(4):283-91.

Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. International journal of surgery. 2012 Jan 1;10(1):28-55.